© 2026 Sinochem Nanjing Corporation,
All Right Reserved
The story of sparfloxacin starts back in the late 1980s, when antibiotic resistance started spoiling the effectiveness of older drugs. Fluoroquinolones had started to catch the attention of researchers, thanks to their broad activity against infectious bacteria. Pharmacopeias seldom mention the struggle that went into creating this particular compound, but anybody who has struggled with resistant infections knows the need that drove its discovery. Laboratories were searching for a balance: kill those bugs but spare the patient as much grief as possible. With many adjustments to molecular structure, sparfloxacin came out of the jumble as an option boasting improved potency, especially against tough respiratory pathogens.
Sparfloxacin belongs to the third generation of fluoroquinolone antibiotics. Most people in healthcare circles recognize it by its spectrum: works on Gram-negative and Gram-positive bacteria and, notably, tackles strains that other medicines had started to miss. For the average patient, it came as a yellowish tablet, often given for lower respiratory tract infections, but hospitals appreciated its value for more resistant bugs. Early on, some excitement bubbled up over how frequently it could knock back persistent infections, a big relief for physicians tired of seeing failed therapies.
Sparfloxacin carries the chemical formula C19H22F2N4O3, and its molecular weight lands near 392.4 g/mol. In a laboratory, it shows up as a pale yellow powder, fairly stable under typical storage conditions. It dissolves more easily in slightly acidic water, which comes in handy during preparation and administration. Light sensitivity means it asks for amber bottles, a reminder that even simple things like sunlight can tinker with safety and performance. Its melting point hovers around 250°C, which prevents accidental decomposition during processing. That extra fluorine atom on the ring determines not only how it fights off bacteria but also how the human body handles the drug.
Manufacturers pay close attention to key thresholds in sparfloxacin: identification by IR or HPLC, purity level above 98%, residual solvents tightly controlled, and water content kept low. Capsules or tablets list active ingredient by strength, frequently 100 mg or 200 mg units, and bear warnings about photosensitivity and QT interval prolongation. Labels highlight prescription-only status, instructions against use in children, and restrictions if the patient already wrestles with heart rhythm problems. Packages show storage temperatures: typically room temperature, away from excess heat and light. A unique batch code allows tracking, keeping quality high and providing transparency from plant to patient.
Sparfloxacin synthesis begins with a quinolone core and then goes through sequential fluorination and introduction of a piperazinyl side chain. Each step needs careful control, not just for yield, but to avoid impurities that can linger into the final drug. The cyclopropyl ring on the core ensures the right activity spectrum. After purification via crystallization and column chromatography, the compound gets milled, then pressed into tablets or filled into capsules. Modern plants use closed systems for solvent handling; no one enjoys breathing in dust or fumes, especially when dealing with potent intermediates.
Chemists tweak the structure by adjusting the position of the fluoride atoms, which changes how the compound interacts with bacterial enzymes. Subtle shifts make the difference between an inactive molecule and one that takes down a stubborn infection. Addition of methyl or cyclopropyl groups on the piperazine ring modifies pharmacokinetics, sometimes extending half-life or boosting tissue penetration. As resistance builds worldwide, labs keep looking at prodrug forms and new salts, always in hopes of pulling some extra benefit in terms of safety or activity.
Sparfloxacin appears under several trade names, most notably "Zagam" in many markets. Generic versions carry the name sparfloxacin plain or as the hydrochloride salt. Researchers and pharmacists sometimes refer to it as CI-978 or AT-4140 during studies or procurement. Synonyms reflect the molecule's history in pharmaceutical research: fluorosparfloxacin, and 5-amino-1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-6,8-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid. Only the boldest chemists recite these without glancing at a reference!
Workers in manufacturing or laboratory settings remember that sparfloxacin, like most fluoroquinolones, cuts both ways: helpful for patients but risky on accidental exposure. Material safety data recommends gloves, eye protection, well-ventilated workspaces, and immediate cleanup of spills. On the clinical side, safety comes down to informed prescribing. Known risks—QT prolongation, photosensitivity, and rare tendon rupture—mean doctors pick this molecule with care, usually after weighing alternatives. Regulatory agencies like the US FDA and EMA have issued guidance on appropriate uses, batch validation, and pharmacovigilance, all meant to keep patients and staff out of trouble.
Sparfloxacin found its place most often in hospital wards managing respiratory infections—chronic bronchitis flare-ups, community-acquired pneumonia, and some skin and soft tissue infections. For patients with cystic fibrosis or bronchiectasis, it represented a new arrow in the quiver when older drugs stopped working. Clinics occasionally used it for urinary tract infections but steered clear in routine cases to hold down the risk of resistance. Use in children, pregnant people, and athletes faded quickly due to side effects like joint and tendon issues.
Academic and industrial labs kept sparfloxacin in their sights years after approval. Pharmacokinetic studies tracked absorption, distribution, half-life, and elimination routes. Gene sequencing and in vitro assays explored the ways resistance evolves—mutations in DNA gyrase, topoisomerase IV, and the impact of efflux pumps. Some of the most meaningful research examined combination therapy: pairing sparfloxacin with beta-lactams or macrolides to cover more ground and prevent resistance. Hospitals also tested the drug against emerging pathogens, sometimes with success, sometimes running into new barriers of safety or pharmacology. Dusty journals document efforts to modify the molecule’s tail to sidestep side effects, often hitting dead ends, but never entirely shelving the idea.
Toxicologists zeroed in on cardiac safety early on. Sparfloxacin lengthens the QT interval, a tweak in the heart's rhythm that can set off dangerous arrhythmias in susceptible patients. Sunburn comes easier with this drug, since it increases skin sensitivity to light, sometimes causing blistering reactions. Animal studies and phase I clinical trials exposed rare concerns about liver and kidney stress, leading to dose adjustments and close monitoring for patients with organ compromise. Specialists debate the risk-benefit balance; some shy away entirely, while others prescribe it with informed consent and oversight. Post-marketing reports have driven label changes and fresh restrictions, showing the ongoing responsibility to patients long after a drug’s launch.
Fluoroquinolone resistance keeps climbing. Every new case of multidrug-resistant tuberculosis or hospital-acquired pneumonia sparks questions about resurrecting or redesigning molecules like sparfloxacin. Research continues focusing on structure-activity relationships, seeking ways to keep potency against evolving bacteria while trimming side effects. Next-generation delivery—using nanoparticles, depot injections, or inhaled forms—keeps interest alive in pharmaceutical circles. Some biotech startups look at hybrid compounds, blending sparfloxacin with other chemical classes in hopes of finding novel therapies. The lessons from this molecule, from tough regulatory reviews to sobering toxicity data, guide both cautious optimism and persistent effort in combatting the next wave of infectious disease.
Sparfloxacin belongs to the family of drugs known as fluoroquinolone antibiotics. Doctors often reach for this medicine to tackle certain kinds of bacterial infections. If someone battles a stubborn chest infection or grapples with chronic bronchitis, sparfloxacin sometimes enters the scene after other treatments disappoint. This medication also counts as an option for pneumonia, especially the type acquired outside of hospital walls.
Infections can knock a person flat for days at a time. As a fluoroquinolone, sparfloxacin disrupts how bacteria reproduce by blocking key enzymes the bug needs to survive. The result: the infection loses ground, and the body’s immune system gains the upper hand.
I remember a time during my pharmacy days when some patients arrived with infections that did not seem to yield to older antibiotics. In a few cases, doctors prescribed sparfloxacin, particularly when routine options failed. It felt like a lifeline to those out of options, and in many cases, noticeable improvement followed.
Every antibiotic comes with its share of risks, and sparfloxacin stands no exception. In fact, some health professionals hesitate to use it unless really necessary. People can run into trouble with sun sensitivity—a few hours outside under bright sunlight may trigger rashes or burns. Moreover, like other drugs in its class, it can upset the balance in one’s digestive tract and sometimes bring tendon aches or even rare tendon ruptures.
The U.S. Food and Drug Administration and similar agencies worldwide require doctors and pharmacists to share information about these risks. Ignoring these signs, pushing through the pain, or staying out in the sun too long can quickly escalate problems. It’s not just about minor discomfort—it may lead to hospitalization or make recovery longer.
Sparfloxacin can also interfere with heart rhythm. People with existing heart problems, or those taking other rhythm-affecting drugs, may need to look elsewhere for treatment. The antibiotic also can interact with certain antacids, supplements, and other common medications, sometimes making it tough for people on complicated regimens.
Doctors lean on sparfloxacin only after weighing several options, not just because of its side effect profile but also its role in antibiotic stewardship. Bacteria adapt fast. Overusing broad-spectrum antibiotics like sparfloxacin helps breed the sort of resistant strains that no one wants to face down the line. These “superbugs” can leave hospitals and clinics scrambling.
Keeping sparfloxacin as a tool in the medical arsenal involves everyone—patients, doctors, pharmacists, and researchers. Patients who finish prescribed courses and avoid skipping doses help slow resistance. Healthcare workers watch for patterns of resistance and report new issues as they appear. Researchers keep looking for faster ways to detect bacterial types so the right antibiotic can be chosen from the start.
With so many antibiotic choices, it takes effort and knowledge to use sparfloxacin wisely. Open conversations about risk, responsibility, and the value of having strong antibiotic options for the future protect not just today’s patients but future generations. For now, sparfloxacin plays a targeted role, stepping in when other answers run short.
Sparfloxacin helps tackle infections that just don’t quit, but popping this antibiotic comes with a set of challenges many don’t hear during those quick doctor visits. I remember a friend who took sparfloxacin prescribed for a stubborn chest infection. Relief came with a tradeoff—he walked away sunburned after a short walk in the park and complained about a constant metallic taste. His experience isn’t unique.
Once you start sparfloxacin, sunlight suddenly turns into an enemy. Even just running errands or driving with the windows down can leave skin red, sore, and peeling. Sometimes, it goes past a regular sunburn. Some people develop a rash, blisters, or swelling. Research published in the “Journal of Antimicrobial Chemotherapy” points to sun-induced skin reactions in a noticeable percentage of patients, stressing that wearing sunscreen or keeping indoors can make a world of difference.
Queue up spare toilet paper if your stomach feels rebellious after swallowing that small white pill. Common complaints include nausea, diarrhea, stomach pain, and bloating. In busy clinics, doctors warn about the risk of Clostridium difficile—when good gut bacteria get knocked out, nasty bugs move in. The U.S. FDA lists digestive issues among the yellow warning signs. Probiotics sometimes help, but the best tip: listen to your gut. If it acts up, seek help right away.
People sometimes brush off dizziness or headache, chalking it up to a missed meal. Under sparfloxacin’s influence, these issues pop up more often. A study by the Mayo Clinic mentions confusion, sleep problems, or even short episodes of being shaky or jumpy. One neighbor down the street went to the ER after feeling off-balance all week, only to find sparfloxacin played a part in her symptoms. Staying hydrated helps, yet anyone groggy or confused deserves attention quickly.
Some folks, especially older adults or those stacking up medications, face heart rhythm changes after starting sparfloxacin. The drug slows down how the heart beats, raising the risk of a condition called QT prolongation—basically, the electrical system gets thrown out of sync. The American Heart Association underscores the need for ECG checks and keeping tabs on potassium and magnesium levels, since the right balance helps avoid these dangerous rhythms. Joint pain and swelling also crop up, particularly for those already dealing with arthritis. Daily walks can become painful, especially in knees and ankles.
Sometimes, medicine acts more like an enemy than a friend. Swelling, hives, and trouble breathing signal a bad allergic reaction—one that needs immediate medical care. The CDC raises red flags for anyone who breaks out or feels their throat tightening, especially during the first few doses.
Doctors carefully weigh benefits and risks before handing out sparfloxacin. Sometimes switching to another antibiotic solves the problem. Simple precautions, such as avoiding extended sun exposure, drinking plenty of fluids, and reporting side effects early, let most people dodge the worst issues. It’s not just about getting rid of the infection; safeguarding the rest of your health takes equal priority. Pharmacists, nurses, and friends who have been through it all bring valuable advice to the table, making it possible to get better without taking unnecessary hits along the way.
Sparfloxacin fights off bacteria that try to set up shop and cause infections, especially in the lungs and sinuses. It falls under the class of medicines called fluoroquinolones. Doctors might pick sparfloxacin for certain cases, often when other antibiotics lose their punch or allergy rules out other options. I’ve seen people expect quick relief, but it takes steady dosing to work.
Taking it with a full glass of water helps. People often wonder if meals matter. You can take sparfloxacin with or without food, but anything heavy in calcium like milk or cheese shouldn’t come with the pill. That stuff can trip up how well your body absorbs the medicine, and that means weaker results.
Doctors usually base the starting dose on the type and intensity of the infection, along with age and kidney function. For most adults, one common schedule goes like this: two pills (400 mg total) on the first day, then one pill (200 mg) once a day after that. This continues for about one and a half weeks, but your doctor might tweak things.
Elderly folks and anyone with kidney struggles need special attention. Too much sparfloxacin can do more harm than good, showing up as nausea, dizziness, or in serious cases, trouble with the heart’s rhythm. Doctors pull out calculators and check kidney blood tests to adjust, not guess.
Don’t just stop taking sparfloxacin once you feel better. This mistake happens more often than people admit, leading to tough, hard-to-kill bacteria. Stick to the full course. Space your doses as evenly as possible, so bacteria never get a break.
Missed a pill? Take it as soon as you remember unless it’s nearly time for your next dose—then just move on. Never double up on doses.
Keep sparfloxacin out of the hands of kids unless a specialist says otherwise. This family of antibiotics can mess with growing cartilage. Pregnant or breastfeeding mothers are almost always steered clear for the same reason.
Certain side effects can make a person want to quit early or reach for a different pill. The big ones: sun sensitivity and skin rashes. Anybody taking sparfloxacin finds the sun seems extra fierce, so sunscreen and covering up is a must, even for short trips outside.
Stomach pain, nausea, and headaches show up in some people. Rare but serious: pain in tendons or swelling in joints. This drug has a reputation for rare heart rhythm problems—something folks with heart trouble ought to talk over with their doctor before starting.
No one should take this drug without advice from a trusted healthcare provider. Doctors check for drug interactions, which covers everyday things like antacids, supplements, or even basic pain relievers. Drug-resistant bacteria don’t just bother hospitals. They grow from too many people taking antibiotics without oversight.
Clear, honest talk with your doctor before and throughout the course leads to better results. This medicine, given respect and careful handling, still does its job in the right hands.
Doctors sometimes choose Sparfloxacin for its ability to knock out stubborn bacterial infections, especially those that haven’t responded well to other treatments. This fluoroquinolone antibiotic has shown effectiveness, but with any strong medicine, there’s a trade-off. Sparfloxacin demands care. In everyday clinical settings, it’s clear that knowing how to use it safely counts for as much as the treatment itself.
Sparfloxacin does more than just target bacteria. It can throw the body’s electrical system off balance, especially in the heart. The drug is linked to dangerous changes on the electrocardiogram, called QT prolongation. This side effect doesn’t just look bad on paper—it can cause a life-threatening heart rhythm problem called Torsades de Pointes. People with a family or personal history of heart rhythm trouble, or those already taking medicines that lengthen the QT interval, face real risk. It's even riskier for those who already have low potassium or magnesium levels.
The drug also hits the skin hard. Even short periods in sunlight can lead to severe sunburn-type reactions. Having seen people show up at clinics with blistering rashes after a weekend outdoors, it’s unforgettable. Recommendations say to stay indoors or under strong sun protection while taking Sparfloxacin and for several days after stopping it.
Mixing medications often leads to trouble, and Sparfloxacin does not play well with others. The risk of rhythm problems goes up with medicines like amiodarone, certain antidepressants, and antipsychotics. Combining Sparfloxacin with nonsteroidal anti-inflammatory drugs (NSAIDs) increases the chance for seizures. Many people take over-the-counter pain relievers daily and don’t realize the risks. Something as common as an antacid or a mineral supplement can block proper absorption, robbing the antibiotic of its chance to work.
Kidney and liver function play a big part in how quickly drugs clear out of the body. Those with reduced kidney function often collect higher levels of Sparfloxacin, raising the risk for side effects. Adjustable dosing turns critical in these cases. Anyone over 65 faces natural declines in kidney function, so observing for side effects in older folks matters even more.
People with a history of tendon problems, especially those caused by quinolone drugs, should steer clear. This drug can tear tendons and heal poorly. Pregnant women and young children are also not good candidates—the risks to developing cartilage outweigh potential benefits. Allergic reactions, sometimes severe, can pop up in people allergic to other quinolones. There’s wisdom in careful questioning before writing that prescription.
Clear communication shapes safe outcomes. Both doctors and patients do better when they have honest discussions about all the medications in use, medical history, any allergies, and daily routines out in the sun. Doctors can choose safer antibiotics for people with existing risk factors or for infections where something less risky will do the trick.
Reading the fine print in healthcare isn’t a luxury— it’s a matter of prevention. Sparfloxacin’s role keeps shrinking in daily practice for good reason. Knowing the full story behind this medicine helps everyone—patients, pharmacists, nurses—look out for pitfalls before they become emergencies.
Most folks picking up a prescription like sparfloxacin probably figure the details start and end at the pharmacy counter. I used to think so, too, until years of working in healthcare changed the way I look at those slip-in information sheets. People assume the biggest risks stem from skipping doses or stopping early, but mixing medicines sets off hidden problems. With sparfloxacin, a strong antibiotic, those risks deserve more than a quick glance.
Sparfloxacin tackles tough infections but doesn’t work in a vacuum. Other drugs in the body may not only affect sparfloxacin’s punch, but can also turn routine treatment into a health scare. For example, some heart medications increase the odds of sparfloxacin causing abnormal heart rhythms. This might seem like a rare statistic, but arrhythmias don’t give much warning, and the consequences can range from dizziness to sudden cardiac events.
People living with diabetes face their own set of worries. Mixing sparfloxacin with certain medications for blood sugar control can throw sugar levels off balance. Infections are scary enough; nobody wants a drug combo making things worse.
Antacids seem harmless, especially compared to antibiotics. Many reach for them after a late-night snack. Adding sparfloxacin changes this story. Calcium, magnesium, and aluminum can drastically lower how much of the antibiotic gets absorbed. Even a glass of milk poured alongside a pill can work against you. I’ve talked to more than a few patients frustrated that a prescribed antibiotic “didn’t do anything,” only to find out antacids or dairy got in the way.
Living with mental health conditions or chronic pain means prescriptions stack up quickly. Sparfloxacin can affect or amplify the impact of certain antidepressants, anti-seizure meds, and painkillers. In some cases, this raises the odds for seizures or other severe reactions. We see reports in journals and case files, but the patients behind those cases have names, jobs, and families. Even one unnecessary hospitalization is too many.
Learning about interaction risks doesn’t mean patients need to memorize every possibility. Open conversations matter more. Letting your doctor or pharmacist know about the full list of pills or supplements can make the difference between smooth recovery and a dangerous setback. Every time I see patients bring a bag of their medicines in for review, it’s a reminder that action — not hidden side effects — belongs in the spotlight.
Online health records and pharmacy systems now catch many dangerous combinations. Still, no system replaces speaking up. Even over-the-counter vitamins and herbal treatments can clash with sparfloxacin, sometimes in surprising ways. Sharing a list feels small, but that habit respects the power of these medicines and, more importantly, respects the person taking them.
Prescription drug interactions create real problems for patients and families. Staying aware, asking questions, and taking a complete list of medicines to appointments still work better than relying on luck. Complications from sparfloxacin deserve genuine attention and a commitment to practical solutions everyone can use.
| Names | |
| Preferred IUPAC name | 5-amino-1-cyclopropyl-7-(3,5-dimethylpiperazin-1-yl)-6,8-difluoro-4-oxoquinoline-3-carboxylic acid |
| Other names |
Sparflo Zagam |
| Pronunciation | /ˌspɑːr.fləˈk-sə.sɪn/ |
| Identifiers | |
| CAS Number | 110871-86-8 |
| 3D model (JSmol) | Here is the **JSmol 3D model string** for **Sparfloxacin**: ``` CC1=CC2=C(C=C1F)N=C(N2C3=CC=C(C=C3)F)C(=O)OCCN4CCOCC4 ``` This is the **SMILES string**, commonly used for input in JSmol and similar tools. |
| Beilstein Reference | 2272206 |
| ChEBI | CHEBI:9156 |
| ChEMBL | CHEMBL416 |
| ChemSpider | 2548 |
| DrugBank | DB01208 |
| ECHA InfoCard | 100000011654 |
| EC Number | 3.5.4.16 |
| Gmelin Reference | 110221 |
| KEGG | D08436 |
| MeSH | D019657 |
| PubChem CID | 5387 |
| RTECS number | DG1125000 |
| UNII | OPX5F8D71S |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID9020239 |
| Properties | |
| Chemical formula | C19H22F2N4O3 |
| Molar mass | 392.414 g/mol |
| Appearance | White to pale yellow crystalline powder |
| Odor | Odorless |
| Density | 1.6 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 0.16 |
| Acidity (pKa) | 6.3 |
| Basicity (pKb) | pKb = 7.18 |
| Magnetic susceptibility (χ) | -47.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.676 |
| Dipole moment | 4.11 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 267.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -595.6 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -5749 kJ/mol |
| Pharmacology | |
| ATC code | J01MA02 |
| Hazards | |
| Main hazards | May cause allergic reactions, phototoxicity, QT interval prolongation, and central nervous system effects. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | Rx", "Pregnancy Risk", "Photosensitivity", "QT Prolongation", "Not for Children |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If swallowed, seek medical advice immediately and show this container or label. Avoid exposure to sunlight or artificial UV rays. Use only as directed by a physician. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 340.8 °C |
| Autoignition temperature | > 482 °C |
| Lethal dose or concentration | LD50 (oral, rat): 1600 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Sparfloxacin: Mouse oral LD50: 3,680 mg/kg |
| NIOSH | SS4025000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 200 mg every 12 hours |
| Related compounds | |
| Related compounds |
Ciprofloxacin Enoxacin Gatifloxacin Levofloxacin Lomefloxacin Moxifloxacin Norfloxacin Ofloxacin |
